XML 19 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating Activities    
Net income $ 41,455 $ 19,317
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]    
Depreciation and amortization, net of accretion 7,803 8,630
(Increase) decrease in cash surrender value of BOLI (455) (460)
Net realized investment (gains) losses (13,280) 8,352
Share-based compensation 3,346 2,715
Deferred income taxes 7,054 2,015
Policy acquisition costs, net amortization (net deferral) (2,376) (570)
Equity in (earnings) loss of unconsolidated subsidiaries (1,808) 3,634
Other (167) 971
Other changes in assets and liabilities:    
Premiums receivable (1,238) (2,849)
Reinsurance related assets and liabilities 2,428 (11,679)
Other assets (5,027) 15,782
Reserve for losses and loss adjustment expenses 3,561 444
Unearned premiums 24,576 25,019
Other liabilities (7,393) (14,339)
Net cash provided (used) by operating activities 58,479 56,982
Purchases of:    
Fixed maturities, available for sale (160,364) (199,590)
Equity securities, trading (35,400) (23,746)
Other investments (3,930) (9,623)
Funding of qualified affordable housing tax credit limited partnerships (37) (702)
Investment in unconsolidated subsidiaries (5,613) (20,581)
Proceeds from sales or maturities of:    
Fixed maturities, available for sale 171,986 225,897
Equity securities, trading 41,584 20,496
Other investments 6,788 4,830
Distributions from unconsolidated subsidiaries 17,848 1,643
Net sales or maturities (purchases) of short-term investments 160,792 (29,130)
Unsettled security transactions, net change 6,296 (229)
Purchases of capital assets (4,535) 0
Other 1,159 (1,100)
Net cash provided (used) by investing activities 196,574 (31,835)
Financing Activities    
Repurchase of common stock 0 (1,301)
Dividends to shareholders (265,664) (69,438)
External capital contribution received for segregated portfolio cells 114 4,336
Other (4,932) (2,532)
Net cash provided (used) by financing activities (270,482) (68,935)
Increase (decrease) in Cash and cash equivalents (15,429) (43,788)
Cash and cash equivalents at beginning of period 117,347 241,100
Cash and cash equivalents at end of period 101,918 197,312
Significant non-cash transactions    
Dividends declared and not yet paid $ 16,516 $ 16,445